Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02324205 · ClinicalTrials.gov registry record · NA
Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)
A NA study, sponsored by GE Healthcare.
- Terminated
- Registry status
- NA
- Development phase
- 196
- Enrollment target
NCT02324205 is a NA study that was terminated before completion, run by GE Healthcare. The registered enrollment target is 196 participants.
The verdict
NCT02324205, a NA study, was terminated before completion, sponsored by GE Healthcare.
- TERMINATED
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
Study Summary
The aim of this recruitment plan (ADAPT-BX) is to collect image and technical data on both digital breast tomosynthesis (DBT) and full-field digital mammography (FFDM), along with other subject data including histology results from biopsy specimen examination and cancer classification data from initially asymptomatic women referred for biopsy after recall from screening and diagnostic work-up. These data will be included in a subsequent and prospectively planned pooled analysis described in a separate protocol (ADAPT-BIE) examining superiority of DBT to FFDM for breast cancer diagnosis and other clinical performance measures.
Interventions
- DEVICE DBT and FFDM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2015-03 |
| Est. Completion | 2017-08-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02324205
The ClinicalTrials.gov registry entry for NCT02324205 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DBT and FFDM is the first listed.
NCT02324205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02324205 about?
NCT02324205 is a clinical study titled "Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)". The aim of this recruitment plan (ADAPT-BX) is to collect image and technical data on both digital breast tomosynthesis (DBT) and full-field digital mammography (FFDM), along with other subject data including histology results from biopsy specimen examination and cancer classification data from init...
What is the current status of trial NCT02324205?
This trial is currently terminated. It is a NA study. The enrollment target is 196 participants. The study started on 2015-03. Estimated completion is 2017-08-29.
What interventions are being tested in trial NCT02324205?
The interventions under investigation include: DBT and FFDM (DEVICE).
Who is sponsoring clinical trial NCT02324205?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.